Indeed supply is severely limited (esp. Outside rich countries, but even inside rich countries if you go back a few months) and demand is extreme.
If this was a free market situation, pfizer would have much much more money.
Indeed supply is severely limited (esp. Outside rich countries, but even inside rich countries if you go back a few months) and demand is extreme.
If this was a free market situation, pfizer would have much much more money.